Securities code: 002294 securities abbreviation: Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) No.: 2022-002 Shenzhen Salubris Pharmaceuticals Co.Ltd(002294)
Announcement of resolutions of the 18th meeting of the 5th board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete
False records, misleading statements or material omissions.
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) (hereinafter referred to as “the company”) the 18th meeting of the Fifth Board of supervisors was held in writing on December 30, 2021, and the meeting notice was delivered by e-mail on December 27, 2021. There are 3 supervisors who should participate, and 3 supervisors who actually participate in the meeting in writing. The number of supervisors present meets the quorum. The meeting was held in accordance with the company law, the articles of association and other relevant provisions.
The attending supervisors deliberated and formed the following resolutions:
1、 At the meeting, 3 people agreed, 0 opposed and 0 abstained, and the proposal on the provision for asset impairment was considered and adopted.
The board of supervisors believes that the provision for asset impairment is in line with the principle of prudence and relevant provisions of the accounting standards for business enterprises, and the basis for the provision is sufficient and in line with the actual situation of the company’s assets; The decision-making procedure of this matter complies with the provisions of relevant laws and regulations and the articles of association, and there is no situation that damages the interests of the company and minority shareholders. The board of supervisors agreed to withdraw the provision for asset impairment this time.
(for details of the announcement on the provision for asset impairment, please refer to the information disclosure media: China Securities Journal, securities times and www.cn.info.com.. CN.)
Documents for future reference
1. The resolution of the board of supervisors signed by the attending supervisors and stamped with the seal of the board of supervisors;
2. Other documents required by SZSE.
It is hereby announced
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) board of supervisors
January 4, 2002
